Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis

Liza Chacko(Imperial College London), Marianna Fontana(Amyloidosis Foundation), Adam Ioannou(The Royal Free Hospital), James Moon(University of Michigan), Daniel Knight(University College London), Aviva Petrie(Eastman Dental Hospital), Dorota Rowczenio(Children's Cancer and Leukaemia Group), Claudio Rapezzi(University of Ferrara), Helen J. Lachmann(Royal Free London NHS Foundation Trust), Mattia Riefolo(Azienda USL di Bologna), Ashutosh Wechelakar(MACOM (United States)), Francesco Bandera(IRCCS Policlinico San Donato), Lucia Venneri(MACOM (United States)), Luciano Potena(Azienda USL di Bologna), Philip N. Hawkins(The Royal Free Hospital), James Brown(MACOM (United States)), Charlotte Manisty(National Institutes of Health), Richard P. Steeds(University Hospitals Birmingham NHS Foundation Trust), Janet A. Gilbertson(The Royal Free Hospital), Rishi Patel(Texas Tech University), Julian D. Gillmore(Alnylam Pharmaceuticals (United States)), Carol Whelan(The Royal Free Hospital), Jonathan Lazari(The Royal Free Hospital), Yousuf Razvi(The Royal Free Hospital), Aldostefano Porcari(Azienda Sanitaria Universitaria Integrata di Trieste), Lodovico Buonamici(The Royal Free Hospital), Candida Cristina Quarta(Boston University), William E. Moody(University Hospitals Birmingham NHS Foundation Trust), Ornella Leone(Policlinico S.Orsola-Malpighi), Nina Karia(The Royal Free Hospital), Ana Martinez–Naharro(Children's Cancer and Leukaemia Group), Beatrice Dal Passo(Azienda Unità Sanitaria Locale di Ferrara)
European Journal of Heart Failure
July 2, 2022
Cited by 83


Related Papers